New Ultra-Low Temperature Freezer Offers Outstanding Sustainability and Sample Protection
A new ultra-low temperature freezer is designed to offer laboratories and biorepositories a greener solution: less power consumption, less noise and higher efficiency without compromising the integrity of samples.
The Thermo Scientific TSX ultra-low temperature freezer features natural refrigerants for lower environmental impact and higher cooling efficiency. Due to its intuitive design, the TSX freezer uses up to 50% less energy than conventional refrigerant ultra-low freezers and delivers temperature uniformity that continuously adapts to a laboratory’s environment.
“Energy efficiency is a feature most lab and biobank managers and sustainability officers look for when making purchasing decisions, but energy savings can come at the expense of sample integrity,” said Chris Champlin, vice president and general manager, Controlled Temperature Technologies at Thermo Fisher Scientific. “The new Thermo Scientific TSX ultra-low temperature freezer delivers unparalleled efficiency, noise reduction, and sample protection. Now, labs and biorepositories can not only reap the benefits of significant energy savings, but also feel confident that their samples are in an environment designed for their protection.”
Conventional ultra-low temperature freezers use single-speed compressors that continually cycle on and off, resulting in poor temperature recovery following door openings. The TSX ultra-low temperature freezer is the only freezer of its kind equipped with the unique V-Drive technology.
When conditions are stable, the V-Drive is designed to operate at a low speed to reduce energy consumption while maintaining a uniform temperature. When dealing with frequent door openings or when samples are added to the freezer, the control system detects the activity and increases the drive speed to bring temperatures quickly back to the set point.
The V-Drive also helps limit sound output to 46 db(A), making the TSX freezer up to 20 times quieter, comparable to a conventional refrigerator. For busy labs and biorepositories, the constant, disruptive noise created by compressors can compromise communications and create a less–than-ideal working environment. What’s more, the freezer utilizes water-blown foam insulation, which eliminates the off-gassing typical of urethane-insulated freezers.
Additional product features include a 600-box sample capacity to maximize storage within a 1.06-m2 footprint, intuitive touch screen interface for access to vital freezer information, and on-board computer and USB port for data storage and exchange.
Related News
-
News Eli Lilly gets ready to launch five new drugs in 2023
Eli Lilly, the American pharmaceutical company (IN, USA) are gearing up for a big year ahead, with hopes to launch five new drugs and capitalise on growing obesity and Alzheimer’s disease markets. -
News Amgen buys Horizon for $27.8 billion in bold step into the rare disease market
Amgen Inc buys pharmaceutical company Horizon Therapeutics in a multibillion-dollar deal, in hopes to capitalise on it's portfolio of drugs in the highly sort after rare disease market. -
News Pharma Supply Chain People Moves
The latest appointments and promotions across the pharmaceutical supply chain. -
News Merck to donate new Ebola vaccine to defend against outbreaks in Uganda
Pharmaceutical giant Merck has announced they will be speeding up the processing of a new vaccine against the latest strain of the Ebola virus, to be donated to a global non-profit organisation for distribution -
News CPHI Podcast Series: Driving innovation with pharmaceutical startups
The latest episode in the CPHI Podcast Series explores how startups are driving innovation by taking high-risk approaches and doing business with greater agility. -
News Greener and efficient processes: Quaternary Ammonium Salts
Quaternary Ammonium Salts play a crucial part in Organic Chemistry processes at many major industries. Discover why.
-
News Biosimilars save patients $11B annually, but barriers to adoption remain in US market
Biosimilars introduce competition into the biologics market, driving down prices and increasing patient access. -
News WHO recommends use of two monoclonal antibody treatments against Ebola
The health body recommended use of treatments by Regeneron and Ridgeback Bio
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance